We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+1.82%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$129B
AUM Growth
-$6.89B
(-5.1%)
Cap. Flow
-$4.94B
Cap. Flow
% of AUM
-3.83%
Top 10 Holdings %
Top 10 Hldgs %
33.07%
Holding
342
New
6
Increased
53
Reduced
242
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$375M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$241M |
| 3 |
Amazon
AMZN
|
+$223M |
| 4 |
Spotify
SPOT
|
+$94.1M |
| 5 |
Applovin
APP
|
+$88.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$773M |
| 2 |
Wells Fargo
WFC
|
+$442M |
| 3 |
Tesla
TSLA
|
+$374M |
| 4 |
Amgen
AMGN
|
+$372M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$295M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.76% |
| 2 | Healthcare | 28.01% |
| 3 | Industrials | 12.89% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Financials | 8.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
TJX Companies
TJX
$178B
| $1.45B | 1.12% |
12,003,367
-303,300
| -2% | -$36.2M |
|
27
NetApp
NTAP
$37.2B
| $1.42B | 1.1% |
12,220,339
-1,207,067
| -9% | -$147M |
|
28
Delta Air Lines
DAL
$60.1B
| $1.33B | 1.03% |
21,932,007
-472,516
| -2% | -$27.9M |
|
29
Thermo Fisher Scientific
TMO
$220B
| $1.3B | 1.01% |
2,505,151
-69,726
| -3% | -$38.3M |
|
30
Bristol-Myers Squibb
BMY
$132B
| $1.29B | 1% |
22,773,180
-596,390
| -3% | -$33.3M |
|
31
JPMorgan Chase
JPM
$950B
| $1.28B | 0.99% |
5,319,450
-327,815
| -6% | -$76.4M |
|
32
Visa
V
$677B
| $1.25B | 0.97% |
3,964,780
-52,290
| -1% | -$15.7M |
|
33
Aecom
ACM
$9.75B
| $1.22B | 0.94% |
11,381,582
-1,129,625
| -9% | -$123M |
|
|
34
Amazon
AMZN
$2.96T
| $1.21B | 0.93% |
5,494,750
+1,089,100
| +25% | +$223M |
|
35
BioMarin Pharmaceuticals
BMRN
$12.4B
| $1.2B | 0.93% |
18,189,171
-678,264
| -4% | -$45.4M |
|
36
Novartis
NVS
$297B
| $1.07B | 0.83% |
11,025,039
-983,016
| -8% | -$105M |
|
37
American Airlines Group
AAL
$10.6B
| $1.05B | 0.81% |
60,225,707
+2,886,041
| +5% | +$41.5M |
|
|
HES
38
DELISTED
Hess
HES
| $1.03B | 0.8% |
7,768,296
-146,649
| -2% | -$20.5M |
|
39
Baidu
BIDU
$37.2B
| $1.02B | 0.79% |
12,114,236
-9,620
| -0.1% | -$878K |
|
40
Royal Caribbean
RCL
$85.6B
| $985M | 0.76% |
4,268,658
-512,485
| -11% | -$113M |
|
|
ONC
41
BeOne Medicines Ltd
ONC
$39.4B
| $942M | 0.73% |
5,098,904
+124,615
| +3% | +$25.5M |
|
42
Intuit
INTU
$89B
| $906M | 0.7% |
1,440,875
-206,161
| -13% | -$132M |
|
|
43
GSK
GSK
$106B
| $854M | 0.66% |
25,261,660
+10,407,905
| +70% | +$375M |
|
44
Analog Devices
ADI
$190B
| $749M | 0.58% |
3,523,385
-54,765
| -2% | -$12.1M |
|
45
HP
HPQ
$27.5B
| $715M | 0.55% |
21,915,405
-425,035
| -2% | -$15.3M |
|
46
ExxonMobil
XOM
$634B
| $702M | 0.54% |
6,522,990
-561,562
| -8% | -$65.7M |
|
47
Walt Disney
DIS
$181B
| $701M | 0.54% |
6,296,234
-139,700
| -2% | -$14.7M |
|
48
Northern Trust
NTRS
$33.9B
| $689M | 0.53% |
6,720,607
-364,510
| -5% | -$37.3M |
|
49
Jacobs Solutions
J
$17B
| $682M | 0.53% |
5,157,921
-166,074
| -3% | -$22.9M |
|
50
TransDigm Group
TDG
$67.7B
| $650M | 0.5% |
513,194
| – | – |
|
Similar funds
VAM
Primecap Management's Q4 2024 Portfolio in Review
As of Q4 2024, Primecap Management held 342 positions worth $129B, down 5.1% from $136B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Primecap Management withdrew a net $4.94B in Q4 2024, closing 13 positions and reducing 242 holdings. Its most notable exit was Southwestern Energy Company, an estimated $52.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Primecap Management opened a new position in Spotify worth $98.3M.
- Primecap Management's largest Q4 2024 buy was Spotify: 219,800 shares worth $98.3M.
- Primecap Management added most to GSK in Q4 2024, an estimated $375M increase.
- Primecap Management's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $773M.
- Primecap Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $52.8M.
- Primecap Management's ten largest holdings make up 33% of its $129B portfolio in Q4 2024.
- Primecap Management opened 6 new positions and closed 13 in Q4 2024.
- Primecap Management's portfolio value fell 5.1% quarter-over-quarter to $129B.
Based on Primecap Management's 13F filing for Q4 2024, filed 10 Feb 2025.